<DOC>
	<DOCNO>NCT00503191</DOCNO>
	<brief_summary>The purpose study determine whether NeuroModulation Technique ( NMT ) effective reduce maladaptive behavior increase adaptive behavior child diagnose autism . Hypothesis : Children Experimental group show significant improvement Wait-List control group measure Pervasive Developmental Disorder Behavioral Inventory ( PDDBI ) , Aberrant Behavior Checklist , Community Version ( ABC-C ) , Autism Treatment Evaluation Checklist ( ATEC ) . Children Wait-List control group show significant improvement baseline measure receive NMT treatment .</brief_summary>
	<brief_title>NeuroModulation Technique Treatment Autism</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Neurodevelopmental Disorders</mesh_term>
	<criteria>Qualified participant receive formal diagnosis autism physician psychologist use DSMIV , DSMIVTR ICD9CM diagnostic criterion . Parents and/or legal guardian must supply proof autism diagnosis . Autism ( DSMIV , DSMIVR ICD9CM 299.0 ) must diagnose diagnosis Pervasive Developmental Disorder ( PDD ) , Pervasive Developmental Disorder Not Otherwise Specified ( PDDNOS ) Asperger Syndrome sufficient inclusion study . Children must diagnosis autism least one year prior date application participation study . Children must start new therapy stop ongoing therapy design treat autism behavior therapy , speech therapy , physical therapy , sensory integration , dietary modification dietary supplementation , alternative experimental therapy mention 6 month prior date application participation study . During course study , child require continue therapy receive prior start study , require start new therapy besides NeuroModulation Technique course study . Parents and/or legal guardian child study must fluent English complete form questionnaire English ( U.S. Canadian research sit ) Excluded participate child follow medical condition : cerebral palsy , Down 's syndrome , traumatic brain injury , encephalitis , Lyme disease , cancer , active infectious disease , endocrine disorder , mental disorder psychotic disorder mood disorder include bipolar disorder , acute , chronic unstable medical condition ( seizure disorder , Crohn 's disease , asthma , bronchitis , etc . ) autism child receive treatment , medication and/or therapy . Also exclude study child undergone chelation therapy past currently undergo chelation therapy , child display significant selfinjurious behavior ( child cause visible harm ) .Children history mild moderate food airborne allergy , sensitivity , mild digestive problem eligible participate study . In order participate study , child must receive previous NeuroModulation Technique treatment .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Autism</keyword>
	<keyword>Neurodevelopmental disorder</keyword>
</DOC>